Skip to main content
Top
Published in: BMC Pregnancy and Childbirth 1/2020

01-12-2020 | Miscarriage | Research article

Burden of hepatitis E virus infection in pregnancy and maternofoetal outcomes: a systematic review and meta-analysis

Authors: Jean Joel Bigna, Abdou Fatawou Modiyinji, Jobert Richie Nansseu, Marie A. Amougou, Moise Nola, Sébastien Kenmoe, Elvis Temfack, Richard Njouom

Published in: BMC Pregnancy and Childbirth | Issue 1/2020

Login to get access

Abstract

Background

There is still a dearth of knowledge on the burden of HEV infection in the global population of pregnant women. Therefore, we conducted a systematic review and meta-analysis to estimate the global burden of HEV infection in pregnancy.

Methods

We searched PubMed, Embase, Web of Knowledge, and Global Index Medicus to identify articles published until January 26, 2020. We considered cross-sectional, case-control, and cohort studies reporting the immunoglobulins M HEV seroprevalence in asymptomatic and symptomatic (jaundice or elevated transaminases) pregnant women or investigating the association between HEV infection and maternofoetal outcomes. We used a random-effects model to pool studies. This review was registered with PROSPERO, CRD42018093820.

Results

For HEV prevalence estimates, we included 52 studies (11,663 pregnant women). The seroprevalence was 3.5% (95% confidence interval: 1.4–6.4) in asymptomatic women (most of whom from high endemic areas). The prevalence in symptomatic women was 49.6% (42.6–56.7) with data only from HEV high endemic countries. In the multivariable meta-regression model, the prevalence was higher in symptomatic women compared to asymptomatic (adjusted prevalence odds ratio [aPOR]: 1.76; 95%CI: 1.61–1.91) and decreased with increasing year of publication (by 10-year) (aPOR: 0.90; 95%CI: 0.84–0.96). The proportion of HEV vertical transmission was 36.9% (13.3–64.2). Risk of bias was low, moderate and high respectively in 12 (23%), 37 (70%), and 4 studies (7%) addressing HEV prevalence estimation. HEV infection was associated with maternal deaths (pooled OR 7.17; 3.32–15.47), low birth weight (OR: 3.23; 1.71–6.10), small for gestational age (OR: 3.63; 1.25–10.49), preterm < 32 weeks (OR: 4.18; 1.23–14.20), and preterm < 37 weeks (OR: 3.45; 2.32–5.13), stillbirth (OR: 2.61; 1.64–4.14), intrauterine deaths (OR: 3.07; 2.13–4.43), and not with miscarriage (OR: 1.74; 0.77–3.90). All studies which assessed the association between HEV infection and maternofoetal outcomes had a moderate risk of bias.

Conclusions

Findings from this study are suggestive of a high burden of HEV infection in pregnancy in high endemic countries, its association with poor maternofoetal outcomes, and a high rate of vertical transmission. This study supports the need for specific strategies to prevent exposure of pregnant women to HEV infection, especially in high endemic areas.
Appendix
Available only for authorised users
Literature
5.
go back to reference Izopet J, Lhomme S, Chapuy-Regaud S, Mansuy JM, Kamar N, Abravanel F. HEV and transfusion-recipient risk. VHE Risque receveur. 2017;24(3):176–81. Izopet J, Lhomme S, Chapuy-Regaud S, Mansuy JM, Kamar N, Abravanel F. HEV and transfusion-recipient risk. VHE Risque receveur. 2017;24(3):176–81.
6.
go back to reference Smith DB, Simmonds P. Hepatitis E virus and fulminant hepatitis--a virus or host-specific pathology? Liver Int. 2015;35(4):1334–40.PubMedCrossRef Smith DB, Simmonds P. Hepatitis E virus and fulminant hepatitis--a virus or host-specific pathology? Liver Int. 2015;35(4):1334–40.PubMedCrossRef
7.
go back to reference Jilani N, Das BC, Husain SA, Baweja UK, Chattopadhya D, Gupta RK, Sardana S, Kar P. Hepatitis E virus infection and fulminant hepatic failure during pregnancy. J Gastroenterol Hepatol. 2007;22(5):676–82.PubMedCrossRef Jilani N, Das BC, Husain SA, Baweja UK, Chattopadhya D, Gupta RK, Sardana S, Kar P. Hepatitis E virus infection and fulminant hepatic failure during pregnancy. J Gastroenterol Hepatol. 2007;22(5):676–82.PubMedCrossRef
8.
go back to reference Borkakoti J, Hazam RK, Mohammad A, Kumar A, Kar P. Does high viral load of hepatitis E virus influence the severity and prognosis of acute liver failure during pregnancy? J Med Virol. 2013;85(4):620–6.PubMedCrossRef Borkakoti J, Hazam RK, Mohammad A, Kumar A, Kar P. Does high viral load of hepatitis E virus influence the severity and prognosis of acute liver failure during pregnancy? J Med Virol. 2013;85(4):620–6.PubMedCrossRef
10.
go back to reference Chaudhry SA, Verma N, Koren G. Hepatitis E infection during pregnancy. Can Fam Phys Med Fam Can. 2015;61(7):607–8. Chaudhry SA, Verma N, Koren G. Hepatitis E infection during pregnancy. Can Fam Phys Med Fam Can. 2015;61(7):607–8.
11.
go back to reference Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (Clin Res ed). 2009;339:b2700.CrossRef Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (Clin Res ed). 2009;339:b2700.CrossRef
13.
go back to reference Hoy D, Brooks P, Woolf A, Blyth F, March L, Bain C, Baker P, Smith E, Buchbinder R. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol. 2012;65(9):934–9.PubMedCrossRef Hoy D, Brooks P, Woolf A, Blyth F, March L, Bain C, Baker P, Smith E, Buchbinder R. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol. 2012;65(9):934–9.PubMedCrossRef
14.
go back to reference Sterne JA, Hernan MA, Reeves BC, Savovic J, Berkman ND, Viswanathan M, Henry D, Altman DG, Ansari MT, Boutron I, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ (Clin Res). 2016;355:i4919. Sterne JA, Hernan MA, Reeves BC, Savovic J, Berkman ND, Viswanathan M, Henry D, Altman DG, Ansari MT, Boutron I, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ (Clin Res). 2016;355:i4919.
15.
go back to reference Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statistic. Fam Med. 2005;37(5):360–3.PubMed Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statistic. Fam Med. 2005;37(5):360–3.PubMed
16.
go back to reference Barendregt JJ, Doi SA, Lee YY, Norman RE, Vos T. Meta-analysis of prevalence. J Epidemiol Community Health. 2013;67(11):974–8.PubMedCrossRef Barendregt JJ, Doi SA, Lee YY, Norman RE, Vos T. Meta-analysis of prevalence. J Epidemiol Community Health. 2013;67(11):974–8.PubMedCrossRef
17.
go back to reference Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clin Res). 1997;315(7109):629–34.CrossRef Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clin Res). 1997;315(7109):629–34.CrossRef
19.
go back to reference Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58.PubMedCrossRef Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58.PubMedCrossRef
20.
go back to reference Cochran WG. The combination of estimates from different experiments. Biometrics. 1954;10(1):101–29.CrossRef Cochran WG. The combination of estimates from different experiments. Biometrics. 1954;10(1):101–29.CrossRef
21.
go back to reference Bhatnagar G, Sharma S, Kumar A, Prasad S, Agarwal S, Kar P. Reduced glutathione in hepatitis E infection and pregnancy outcome. J Obstet Gynaecol Res. 2016;42(7):789–95.PubMedCrossRef Bhatnagar G, Sharma S, Kumar A, Prasad S, Agarwal S, Kar P. Reduced glutathione in hepatitis E infection and pregnancy outcome. J Obstet Gynaecol Res. 2016;42(7):789–95.PubMedCrossRef
22.
go back to reference Devi SG, Kumar A, Kar P, Husain SA, Sharma S. Association of pregnancy outcome with cytokine gene polymorphisms in HEV infection during pregnancy. J Med Virol. 2014;86(8):1366–76.PubMedCrossRef Devi SG, Kumar A, Kar P, Husain SA, Sharma S. Association of pregnancy outcome with cytokine gene polymorphisms in HEV infection during pregnancy. J Med Virol. 2014;86(8):1366–76.PubMedCrossRef
23.
go back to reference Javed NA, Ullah SH, Hussain N, Sheikh MA, Khan A, Ghafoor F, Firdous R, Uddin W, Saqib AN, Muhyudin G. Hepatitis e virus seroprevalence in pregnant women in Pakistan: maternal and fetal outcomes. East Mediterr Health J. 2017;23(8):559–63.PubMedCrossRef Javed NA, Ullah SH, Hussain N, Sheikh MA, Khan A, Ghafoor F, Firdous R, Uddin W, Saqib AN, Muhyudin G. Hepatitis e virus seroprevalence in pregnant women in Pakistan: maternal and fetal outcomes. East Mediterr Health J. 2017;23(8):559–63.PubMedCrossRef
24.
go back to reference Kumar A, Devi SG, Kar P, Agarwal S, Husain SA, Gupta RK, Sharma S. Association of cytokines in hepatitis E with pregnancy outcome. Cytokine. 2014;65(1):95–104.PubMedCrossRef Kumar A, Devi SG, Kar P, Agarwal S, Husain SA, Gupta RK, Sharma S. Association of cytokines in hepatitis E with pregnancy outcome. Cytokine. 2014;65(1):95–104.PubMedCrossRef
25.
go back to reference Patra S, Kumar A, Trivedi SS, Puri M, Sarin SK. Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection. Ann Intern Med. 2007;147(1):28–33.PubMedCrossRef Patra S, Kumar A, Trivedi SS, Puri M, Sarin SK. Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection. Ann Intern Med. 2007;147(1):28–33.PubMedCrossRef
26.
go back to reference Abebe M, Ali I, Ayele S, Overbo J, Aseffa A, Mihret A. Seroprevalence and risk factors of Hepatitis E Virus infection among pregnant women in Addis Ababa, Ethiopia. PLoS One. 2017;12(6). Abebe M, Ali I, Ayele S, Overbo J, Aseffa A, Mihret A. Seroprevalence and risk factors of Hepatitis E Virus infection among pregnant women in Addis Ababa, Ethiopia. PLoS One. 2017;12(6).
27.
go back to reference Adjei AA, Tettey Y, Aviyase JT, Adu-Gyamfi C, Obed S, Mingle JA, Ayeh-Kumi PF, Adiku TK. Hepatitis e virus infection is highly prevalent among pregnant women in Accra, Ghana. Virol J. 2009;6. Adjei AA, Tettey Y, Aviyase JT, Adu-Gyamfi C, Obed S, Mingle JA, Ayeh-Kumi PF, Adiku TK. Hepatitis e virus infection is highly prevalent among pregnant women in Accra, Ghana. Virol J. 2009;6.
28.
go back to reference Ahmed RE, Karsany MS, Adam I. Brief report: acute viral hepatitis and poor maternal and perinatal outcomes in pregnant Sudanese women. J Med Virol. 2008;80(10):1747–8.PubMedCrossRef Ahmed RE, Karsany MS, Adam I. Brief report: acute viral hepatitis and poor maternal and perinatal outcomes in pregnant Sudanese women. J Med Virol. 2008;80(10):1747–8.PubMedCrossRef
29.
go back to reference Singla A, Mehta S, Rajaram S, Shree S. Materno-fetal outcomes with viral hepatitis in pregnancy. J Obstet Gynecol India. 2016;66(3):166–9.CrossRef Singla A, Mehta S, Rajaram S, Shree S. Materno-fetal outcomes with viral hepatitis in pregnancy. J Obstet Gynecol India. 2016;66(3):166–9.CrossRef
30.
go back to reference Banait VS, Sandur V, Parikh F, Murugesh M, Ranka P, Ramesh VS, Sasidharan M, Sattar A, Kamat S, Dalal A, et al. Outcome of acute liver failuredue to acute hepatitis E in pregnant women. Indian J Gastroenterol. 2007;26(1):6–10.PubMed Banait VS, Sandur V, Parikh F, Murugesh M, Ranka P, Ramesh VS, Sasidharan M, Sattar A, Kamat S, Dalal A, et al. Outcome of acute liver failuredue to acute hepatitis E in pregnant women. Indian J Gastroenterol. 2007;26(1):6–10.PubMed
31.
go back to reference Beniwal M, Kumar A, Kar P, Jilani N, Sharma JB. Prevalence and severity of acute viral hepatitis and fulminant hepatitis during pregnancy: a prospective study from North India. Indian J Med Microbiol. 2003;21(3):184–5.PubMedCrossRef Beniwal M, Kumar A, Kar P, Jilani N, Sharma JB. Prevalence and severity of acute viral hepatitis and fulminant hepatitis during pregnancy: a prospective study from North India. Indian J Med Microbiol. 2003;21(3):184–5.PubMedCrossRef
32.
go back to reference Bhatia V, Singhal A, Panda SK, Acharya SK. A 20-year single-center experience with acute liver failure during pregnancy: Is the prognosis really worse? Hepatology (Baltimore, Md). 2008;48(5):1577–85.CrossRef Bhatia V, Singhal A, Panda SK, Acharya SK. A 20-year single-center experience with acute liver failure during pregnancy: Is the prognosis really worse? Hepatology (Baltimore, Md). 2008;48(5):1577–85.CrossRef
33.
go back to reference Bista BK, Rana A. Acute hepatitis E in pregnancy--study of 16 cases. JNMA. 2006;45(161):182–5. Bista BK, Rana A. Acute hepatitis E in pregnancy--study of 16 cases. JNMA. 2006;45(161):182–5.
34.
go back to reference Brohi ZP, Sadaf A, Perveen U. Etiology, clinical features and outcome of fulminant hepatic failure in pregnancy. J Pak Med Assoc. 2013;63(9):1168–71.PubMed Brohi ZP, Sadaf A, Perveen U. Etiology, clinical features and outcome of fulminant hepatic failure in pregnancy. J Pak Med Assoc. 2013;63(9):1168–71.PubMed
35.
go back to reference Cordova CMMd, Blatt SL, Botelho TKR, Dalmarco EM: Sorologia Para o vírus da Hepatite E em gestantes: clinicamente importante ou desnecessário? Rev Bras Anal Clin 2007, 39(4):269–273. Cordova CMMd, Blatt SL, Botelho TKR, Dalmarco EM: Sorologia Para o vírus da Hepatite E em gestantes: clinicamente importante ou desnecessário? Rev Bras Anal Clin 2007, 39(4):269–273.
36.
go back to reference Cevrioglu AS, Altindis M, Tanir HM, Aksoy F. Investigation of the incidence of hepatitis E virus among pregnant women in Turkey. J Obstet Gynaecol Res. 2004;30(1):48–52.PubMedCrossRef Cevrioglu AS, Altindis M, Tanir HM, Aksoy F. Investigation of the incidence of hepatitis E virus among pregnant women in Turkey. J Obstet Gynaecol Res. 2004;30(1):48–52.PubMedCrossRef
37.
go back to reference Changede P, Chavan N, Raj N, Gupta P. An observational study to evaluate the maternal and Foetal outcomes in pregnancies complicated with jaundice. J Obstet Gynecol India. 2018:1–6. Changede P, Chavan N, Raj N, Gupta P. An observational study to evaluate the maternal and Foetal outcomes in pregnancies complicated with jaundice. J Obstet Gynecol India. 2018:1–6.
38.
go back to reference Cong W, Sui JC, Zhang XY, Qian AD, Chen J, Zhu XQ. Seroprevalence of hepatitis E virus among pregnant women and control subjects in China. J Med Virol. 2015;87(3):446–50.PubMedCrossRef Cong W, Sui JC, Zhang XY, Qian AD, Chen J, Zhu XQ. Seroprevalence of hepatitis E virus among pregnant women and control subjects in China. J Med Virol. 2015;87(3):446–50.PubMedCrossRef
39.
go back to reference De Paschale M, Ceriani C, Romanò L, Cerulli T, Cagnin D, Cavallari S, Ndayake J, Zaongo D, Diombo K, Priuli G, et al. Epidemiology of hepatitis E virus infection during pregnancy in Benin. Trop Med Int Health. 2016;21(1):108–13.PubMedCrossRef De Paschale M, Ceriani C, Romanò L, Cerulli T, Cagnin D, Cavallari S, Ndayake J, Zaongo D, Diombo K, Priuli G, et al. Epidemiology of hepatitis E virus infection during pregnancy in Benin. Trop Med Int Health. 2016;21(1):108–13.PubMedCrossRef
40.
go back to reference Elduma AH, Osman WM. Dengue and hepatitis E virus infection in pregnant women in eastern Sudan, a challenge for diagnosis in an endemic area. Pan African Med J. 2014;19. Elduma AH, Osman WM. Dengue and hepatitis E virus infection in pregnant women in eastern Sudan, a challenge for diagnosis in an endemic area. Pan African Med J. 2014;19.
41.
go back to reference Farshadpour F, Taherkhani R, Ravanbod MR, Eghbali SS, Taherkhani S, Mahdavi E. Prevalence, risk factors and molecular evaluation of hepatitis E virus infection among pregnant women resident in the northern shores of Persian Gulf, Iran. PLoS One. 2018;13(1). Farshadpour F, Taherkhani R, Ravanbod MR, Eghbali SS, Taherkhani S, Mahdavi E. Prevalence, risk factors and molecular evaluation of hepatitis E virus infection among pregnant women resident in the northern shores of Persian Gulf, Iran. PLoS One. 2018;13(1).
42.
go back to reference Hamid SS, Jafri SMW, Khan H, Shah H, Abbas Z, Fields H. Fulminant hepatic failure in pregnant women: acute fatty liver or acute vital hepatitis? J Hepatol. 1996;25(1):20–7.PubMedCrossRef Hamid SS, Jafri SMW, Khan H, Shah H, Abbas Z, Fields H. Fulminant hepatic failure in pregnant women: acute fatty liver or acute vital hepatitis? J Hepatol. 1996;25(1):20–7.PubMedCrossRef
43.
go back to reference Hannachi N, Hidar S, Harrabi I, Mhalla S, Marzouk M, Ghzel H, Ghannem H, Khairi H, Boukadida J. Seroprevalence and risk factors of hepatitis E among pregnant women in Central Tunisia. Pathol Biol. 2011;59(5):e115–8.PubMedCrossRef Hannachi N, Hidar S, Harrabi I, Mhalla S, Marzouk M, Ghzel H, Ghannem H, Khairi H, Boukadida J. Seroprevalence and risk factors of hepatitis E among pregnant women in Central Tunisia. Pathol Biol. 2011;59(5):e115–8.PubMedCrossRef
44.
go back to reference Huang F, Ma T, Li L, Zeng W, Jing S. Low seroprevalence of hepatitis E virus infection in pregnant women in Yunnan, China. Braz J Infect Dis. 2013;17(6):716–7.PubMedCrossRef Huang F, Ma T, Li L, Zeng W, Jing S. Low seroprevalence of hepatitis E virus infection in pregnant women in Yunnan, China. Braz J Infect Dis. 2013;17(6):716–7.PubMedCrossRef
45.
go back to reference Huang F, Wang J, Yang C, Long F, Li Y, Li L, Jing S, Wang H. Chinese pregnant women in their third trimester are more susceptible to HEV infection. Braz J Infect Dis. 2015;19(6):672–4.PubMedCrossRef Huang F, Wang J, Yang C, Long F, Li Y, Li L, Jing S, Wang H. Chinese pregnant women in their third trimester are more susceptible to HEV infection. Braz J Infect Dis. 2015;19(6):672–4.PubMedCrossRef
46.
go back to reference Jaiswal SPB, Jain AK, Naik G, Soni N, Chitnis DS. Viral hepatitis during pregnancy. Int J Gynecol Obstet. 2001;72(2):103–8.CrossRef Jaiswal SPB, Jain AK, Naik G, Soni N, Chitnis DS. Viral hepatitis during pregnancy. Int J Gynecol Obstet. 2001;72(2):103–8.CrossRef
47.
go back to reference Jilani N, Das BC, Husain SA, Baweja UK, Chattopadhya D, Gupta RK, Sardana S, Kar P. Hepatitis E virus infection and fulminant hepatic failure during pregnancy. J Gastroenterol Hepatol (Australia). 2007;22(5):676–82.CrossRef Jilani N, Das BC, Husain SA, Baweja UK, Chattopadhya D, Gupta RK, Sardana S, Kar P. Hepatitis E virus infection and fulminant hepatic failure during pregnancy. J Gastroenterol Hepatol (Australia). 2007;22(5):676–82.CrossRef
48.
go back to reference Junaid SA, Agina SE, Abubakar KA. Epidemiology and associated risk factors of hepatitis E virus infection in plateau state, Nigeria. Virology. 2014;5:15–26.PubMedPubMedCentral Junaid SA, Agina SE, Abubakar KA. Epidemiology and associated risk factors of hepatitis E virus infection in plateau state, Nigeria. Virology. 2014;5:15–26.PubMedPubMedCentral
49.
go back to reference Kar P, Jilani N, Husain SA, Pasha ST, Anand R, Rai A, Das BC. Does hepatitis E viral load and genotypes influence the final outcome of acute liver failure during pregnancy? Am J Gastroenterol. 2008;103(10):2495–501.PubMedCrossRef Kar P, Jilani N, Husain SA, Pasha ST, Anand R, Rai A, Das BC. Does hepatitis E viral load and genotypes influence the final outcome of acute liver failure during pregnancy? Am J Gastroenterol. 2008;103(10):2495–501.PubMedCrossRef
50.
go back to reference Khuroo MS, Kamili S. Aetiology, clinical course and outcome of sporadic acute viral hepatitis in pregnancy. J Viral Hepat. 2003;10(1):61–9.PubMedCrossRef Khuroo MS, Kamili S. Aetiology, clinical course and outcome of sporadic acute viral hepatitis in pregnancy. J Viral Hepat. 2003;10(1):61–9.PubMedCrossRef
51.
go back to reference Khuroo MS, Kamili S. Aetiology and prognostic factors in acute liver failure in India. J Viral Hepat. 2003;10(3):224–31.PubMedCrossRef Khuroo MS, Kamili S. Aetiology and prognostic factors in acute liver failure in India. J Viral Hepat. 2003;10(3):224–31.PubMedCrossRef
52.
go back to reference Kumar A, Sharma S, Kar P, Agarwal S, Ramji S, Husain SA, Prasad S, Sharma S. Impact of maternal nutrition in hepatitis E infection in pregnancy. Arch Gynecol Obstet. 2017;296(5):885–95.PubMedCrossRef Kumar A, Sharma S, Kar P, Agarwal S, Ramji S, Husain SA, Prasad S, Sharma S. Impact of maternal nutrition in hepatitis E infection in pregnancy. Arch Gynecol Obstet. 2017;296(5):885–95.PubMedCrossRef
53.
go back to reference Kumar S, Pujhari SK, Chawla YK, Chakraborti A, Ratho RK. Molecular detection and sequence analysis of hepatitis E virus in patients with viral hepatitis from North India. Diagn Microbiol Infect Dis. 2011;71(2):110–7.PubMedCrossRef Kumar S, Pujhari SK, Chawla YK, Chakraborti A, Ratho RK. Molecular detection and sequence analysis of hepatitis E virus in patients with viral hepatitis from North India. Diagn Microbiol Infect Dis. 2011;71(2):110–7.PubMedCrossRef
54.
go back to reference Kumar RM, Uduman S, Rana S, Kochiyil JK, Usmani A, Thomas L. Sero-prevalence and mother-to-infant transmission of hepatitis E virus among pregnant women in the United Arab Emirates. Eur J Obstet Gynecol Reprod Biol. 2001;100(1):9–15.PubMedCrossRef Kumar RM, Uduman S, Rana S, Kochiyil JK, Usmani A, Thomas L. Sero-prevalence and mother-to-infant transmission of hepatitis E virus among pregnant women in the United Arab Emirates. Eur J Obstet Gynecol Reprod Biol. 2001;100(1):9–15.PubMedCrossRef
55.
go back to reference Kumar N, Das V, Agarwal A, Pandey A, Agrawal S. Fetomaternal outcomes in pregnant women with hepatitis e infection; still an important fetomaternal killer with an unresolved mystery of increased virulence in pregnancy. Turk Jinekoloji Obstet Dernegi Dergisi. 2017;14(2):106–13. Kumar N, Das V, Agarwal A, Pandey A, Agrawal S. Fetomaternal outcomes in pregnant women with hepatitis e infection; still an important fetomaternal killer with an unresolved mystery of increased virulence in pregnancy. Turk Jinekoloji Obstet Dernegi Dergisi. 2017;14(2):106–13.
56.
go back to reference Kumar S, Ratho RK, Chawla YK, Chakraborti A. The incidence of sporadic viral hepatitis in North India: a preliminary study. Hepatobil Pancreatic Dis Int. 2007;6(6):596–9. Kumar S, Ratho RK, Chawla YK, Chakraborti A. The incidence of sporadic viral hepatitis in North India: a preliminary study. Hepatobil Pancreatic Dis Int. 2007;6(6):596–9.
57.
go back to reference Kumar A, Beniwal M, Kar P, Sharma JB, Murthy NS. Hepatitis E in pregnancy. Int J Gynecol Obstet. 2004;85(3):240–4.CrossRef Kumar A, Beniwal M, Kar P, Sharma JB, Murthy NS. Hepatitis E in pregnancy. Int J Gynecol Obstet. 2004;85(3):240–4.CrossRef
58.
go back to reference Lindemann MLM, Gabilondo G, Romero B, De La Maza OMS, Pérez-Gracia MT. Low prevalence of hepatitis E infection among pregnant women in Madrid, Spain. J Med Virol. 2010;82(10):1666–8.PubMedCrossRef Lindemann MLM, Gabilondo G, Romero B, De La Maza OMS, Pérez-Gracia MT. Low prevalence of hepatitis E infection among pregnant women in Madrid, Spain. J Med Virol. 2010;82(10):1666–8.PubMedCrossRef
59.
go back to reference Mahtab MA, Rahman S, Khan M, Mamum AA, Afroz S. Etiology of fulminant hepatic failure: experience from a tertiary hospital in Bangladesh. Hepatobil Pancreatic Dis Int. 2008;7(2):161–4. Mahtab MA, Rahman S, Khan M, Mamum AA, Afroz S. Etiology of fulminant hepatic failure: experience from a tertiary hospital in Bangladesh. Hepatobil Pancreatic Dis Int. 2008;7(2):161–4.
60.
go back to reference Neffatti H, Lebraud P, Hottelet C, Gharbi J, Challouf T, Roque-Afonso AM. Southern Tunisia: A still high endemicity area for hepatitis A. PLoS One. 2017;12(4). Neffatti H, Lebraud P, Hottelet C, Gharbi J, Challouf T, Roque-Afonso AM. Southern Tunisia: A still high endemicity area for hepatitis A. PLoS One. 2017;12(4).
61.
go back to reference Obiri-Yeboah D, Awuku YA, Adu J, Pappoe F, Obboh E, Nsiah P, Amoako-Sakyi D, Simpore J. Sero-prevalence and risk factors for hepatitis E virus infection among pregnant women in the Cape Coast Metropolis, Ghana. PLoS One. 2018;13(1). Obiri-Yeboah D, Awuku YA, Adu J, Pappoe F, Obboh E, Nsiah P, Amoako-Sakyi D, Simpore J. Sero-prevalence and risk factors for hepatitis E virus infection among pregnant women in the Cape Coast Metropolis, Ghana. PLoS One. 2018;13(1).
62.
go back to reference Pujol FH, Favorov MO, Marcano T, Este JA, Magris M, Liprandi F, Khudyakov YE, Khudyakova NS, Fields HA. Prevalence of antibodies against hepatitis E virus among urban and rural populations in Venezuela. J Med Virol. 1994;42(3):234–6.PubMedCrossRef Pujol FH, Favorov MO, Marcano T, Este JA, Magris M, Liprandi F, Khudyakov YE, Khudyakova NS, Fields HA. Prevalence of antibodies against hepatitis E virus among urban and rural populations in Venezuela. J Med Virol. 1994;42(3):234–6.PubMedCrossRef
63.
go back to reference Rathi U, Bapat M, Rathi P, Abraham P. Effect of liver disease on maternal and fetal outcome a prospective study. Indian J Gastroenterol. 2007;26(2):59–63.PubMed Rathi U, Bapat M, Rathi P, Abraham P. Effect of liver disease on maternal and fetal outcome a prospective study. Indian J Gastroenterol. 2007;26(2):59–63.PubMed
64.
go back to reference Renou C, Gobert V, Locher C, Moumen A, Timbely O, Savary J, Roque-Afonso AM. Prospective study of Hepatitis e Virus infection among pregnant women in France. Virol J. 2014;11(1). Renou C, Gobert V, Locher C, Moumen A, Timbely O, Savary J, Roque-Afonso AM. Prospective study of Hepatitis e Virus infection among pregnant women in France. Virol J. 2014;11(1).
65.
go back to reference Sahai S, Mishra V, Ganga D, Jatav OP. Viral hepatitis in pregnancy--a study of its effect on maternal and Foetal outcome. J Assoc Physicians India. 2015;63(1):28–33.PubMed Sahai S, Mishra V, Ganga D, Jatav OP. Viral hepatitis in pregnancy--a study of its effect on maternal and Foetal outcome. J Assoc Physicians India. 2015;63(1):28–33.PubMed
66.
go back to reference Salam GD, Kumar A, Kar P, Aggarwal S, Husain A, Sharma S. Serum tumor necrosis factor-alpha level in hepatitis E virus-related acute viral hepatitis and fulminant hepatic failure in pregnant women. Hepatol Res. 2013;43(8):826–35.PubMedCrossRef Salam GD, Kumar A, Kar P, Aggarwal S, Husain A, Sharma S. Serum tumor necrosis factor-alpha level in hepatitis E virus-related acute viral hepatitis and fulminant hepatic failure in pregnant women. Hepatol Res. 2013;43(8):826–35.PubMedCrossRef
67.
go back to reference Singh S, Mohanty A, Joshi YK, Deka D, Mohanty S, Panda SK. Mother-to-child transmission of hepatitis E virus infection. Indian J Pediatr. 2003;70(1):37–9.PubMedCrossRef Singh S, Mohanty A, Joshi YK, Deka D, Mohanty S, Panda SK. Mother-to-child transmission of hepatitis E virus infection. Indian J Pediatr. 2003;70(1):37–9.PubMedCrossRef
68.
go back to reference Solanke D, Rathi C, Pandey V, Patil M, Phadke A, Sawant P. Etiology, clinical profile, and outcome of liver disease in pregnancy with predictors of maternal mortality: a prospective study from Western India. Indian J Gastroenterol. 2016;35(6):450–8.PubMedCrossRef Solanke D, Rathi C, Pandey V, Patil M, Phadke A, Sawant P. Etiology, clinical profile, and outcome of liver disease in pregnancy with predictors of maternal mortality: a prospective study from Western India. Indian J Gastroenterol. 2016;35(6):450–8.PubMedCrossRef
69.
go back to reference Strand RT, Franque-Ranque M, Bergström S, Weiland O. Infectious aetiology of jaundice among pregnant women in Angola. Scand J Infect Dis. 2003;35(6–7):401–3.PubMedCrossRef Strand RT, Franque-Ranque M, Bergström S, Weiland O. Infectious aetiology of jaundice among pregnant women in Angola. Scand J Infect Dis. 2003;35(6–7):401–3.PubMedCrossRef
70.
go back to reference Sultana R, Humayun S. Fetomaternal outcome in acute hepatitis E. J Coll Phys Surg Pak. 2014;24(2):127–30. Sultana R, Humayun S. Fetomaternal outcome in acute hepatitis E. J Coll Phys Surg Pak. 2014;24(2):127–30.
71.
go back to reference Surya IGP, Kornia K, Suwardewa TGA, Mulyanto, Tsuda F, Mishiro S. Serological markers of hepatitis B, C, and E viruses and human immunodeficiency virus type-1 infections in pregnant women in Bali, Indonesia. J Med Virol. 2005;75(4):499–503.PubMedCrossRef Surya IGP, Kornia K, Suwardewa TGA, Mulyanto, Tsuda F, Mishiro S. Serological markers of hepatitis B, C, and E viruses and human immunodeficiency virus type-1 infections in pregnant women in Bali, Indonesia. J Med Virol. 2005;75(4):499–503.PubMedCrossRef
72.
go back to reference Modiyinji AF, Amougou-Atsama M, Monamele CG, Nola M, Njouom R. Seroprevalence of hepatitis E virus antibodies in different human populations of Cameroon. J Med Virol. 2019;91(11):1989–94.PubMedCrossRef Modiyinji AF, Amougou-Atsama M, Monamele CG, Nola M, Njouom R. Seroprevalence of hepatitis E virus antibodies in different human populations of Cameroon. J Med Virol. 2019;91(11):1989–94.PubMedCrossRef
73.
go back to reference Tejada-Strop A, Tohme RA, Andre-Alboth J, Childs L, Ji X, Landgraf DO, De Castro V, Boncy J, Kamili S. Seroprevalence of hepatitis a and hepatitis e viruses among pregnant women in Haiti. Am J Trop Med Hyg. 2019;101(1):230–2.PubMedPubMedCentralCrossRef Tejada-Strop A, Tohme RA, Andre-Alboth J, Childs L, Ji X, Landgraf DO, De Castro V, Boncy J, Kamili S. Seroprevalence of hepatitis a and hepatitis e viruses among pregnant women in Haiti. Am J Trop Med Hyg. 2019;101(1):230–2.PubMedPubMedCentralCrossRef
74.
go back to reference Rein DB, Stevens GA, Theaker J, Wittenborn JS, Wiersma ST. The global burden of hepatitis E virus genotypes 1 and 2 in. Hepatology (Baltimore, Md) 2012. 2005;55(4):988–97.CrossRef Rein DB, Stevens GA, Theaker J, Wittenborn JS, Wiersma ST. The global burden of hepatitis E virus genotypes 1 and 2 in. Hepatology (Baltimore, Md) 2012. 2005;55(4):988–97.CrossRef
75.
go back to reference Lata I. Hepatobiliary diseases during pregnancy and their management: an update. Int J Crit Illness Inj Sci. 2013;3(3):175–82.CrossRef Lata I. Hepatobiliary diseases during pregnancy and their management: an update. Int J Crit Illness Inj Sci. 2013;3(3):175–82.CrossRef
76.
go back to reference Fiore S, Savasi V. Treatment of viral hepatitis in pregnancy. Expert Opin Pharmacother. 2009;10(17):2801–9.PubMedCrossRef Fiore S, Savasi V. Treatment of viral hepatitis in pregnancy. Expert Opin Pharmacother. 2009;10(17):2801–9.PubMedCrossRef
Metadata
Title
Burden of hepatitis E virus infection in pregnancy and maternofoetal outcomes: a systematic review and meta-analysis
Authors
Jean Joel Bigna
Abdou Fatawou Modiyinji
Jobert Richie Nansseu
Marie A. Amougou
Moise Nola
Sébastien Kenmoe
Elvis Temfack
Richard Njouom
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Pregnancy and Childbirth / Issue 1/2020
Electronic ISSN: 1471-2393
DOI
https://doi.org/10.1186/s12884-020-03116-2

Other articles of this Issue 1/2020

BMC Pregnancy and Childbirth 1/2020 Go to the issue